Biosimilar Testing Services Market

Future Market Insights

Key Insight

The biosimilar testing services market is projected to grow from USD 4.4 billion in 2025 to USD 14.4 billion by 2035, at a CAGR of 12.5%. Pharmacokinetic Assay will dominate with a 38.2% market share, while elisa will lead the test type segment with a 44.7% share.

October 10, 2025

Anurag Sharma

260 Pages

Cite this Report

Biosimilar Testing Services Market

https://www.futuremarketinsights.com/reports/biosimilar-testing-services-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Antibody Analytics
Charles River Laboratories International Inc
Eurofins Scientific
Intertek Group plc
Kymos Pharma Services
LAB Holdings
Medicilon
Merck KGaA
PPD Inc.
Pacific BioLabs
Profacgen
SGS SA
Sartorius AG

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Biosimilar Testing Services Market

Key Players

Similar Industry Reports